The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Open accessAbstract
Fibrotic diseases encompass a wide spectrum of clinical entities including systemic fibrotic diseases such as systemic sclerosis, sclerodermatous graft versus host disease, nephrogenic systemic fibrosis, and IgG4-associated sclerosing disease, as well as numerous organ-specific disorders including radiation-induced fibrosis, and cardiac, pulmonary, liver, and kidney fibrosis. Although their causative mechanisms are quite diverse, these diseases share the common feature of an uncontrolled and progressive accumulation of fibrous tissue macromolecules in affected organs leading to their dysfunction and ultimate failure. The pathogenesis of fibrotic diseases is complex and despite extensive investigation has remained elusive. Numerous studies have identified myofibroblasts as the cells responsible for the establishment and progression of the fibrotic process. Tissue myofibroblasts in fibrotic diseases originate from several sources including quiescent tissue fibroblasts, circulating CD34+ fibrocytes, and the phenotypic conversion of various cell types including epithelial and endothelial cells into activated myofibroblasts. However, the role of the phenotypic transition of endothelial cells into mesenchymal cells (Endothelial to Mesenchymal Transition or EndoMT) in the pathogenesis of fibrotic disorders has not been fully elucidated. Here, we review the evidence supporting EndoMT’s contribution to human fibrotic disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Stone, J. H., Zen, Y., & Deshpande, V. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1104650 · Cited by 2,616
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Humphreys, B. D., Lin, S.-L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., & Duffield, J. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090517 · Cited by 1,442
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Kamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Biernacka, A., Dobaczewski, M., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,161
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
Kramann, R., Schneider, R. K., DiRocco, D. P., Machado, F., Fleig, S., Bondzie, P. A., Henderson, J. M., Ebert, B. L., & Humphreys, B. D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.004 · Cited by 922 · cited 1×
“These studies have shown that myofibroblasts can originate from various sources including expansion and activation of quiescent resident tissue fibroblasts [42], migration and tissue accumulation of bone marrow-derived CD34+ fibrocytes [43,44], or from the phenotypic transition of epithelial cells, a process known as…”
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050513 · Cited by 876
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852 · cited 1×
“The role of NOX4 as an important downstream mediator of TGF-β-induced myofibroblast generation, its contribution to the potent TGF-β profibrotic effects, and its participation in the pathogenesis of tissue fibrosis in various fibrotic disorders such as IPF and liver fibrosis have been recently demonstrated [135–144].”
BackgroundCucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
Grande, M. T., Sánchez-Laorden, B., López-Blau, C., De Frutos, C. A., Boutet, A., Arévalo, M., Rowe, R. G., Weiss, S. J., López-Novoa, J. M., & Nieto, M. A. (2015) · Nature Medicine · doi:10.1038/nm.3901 · Cited by 783
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
Liu, R.-M., & Desai, L. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.009 · Cited by 702
Razani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 639
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Cellular and molecular mechanisms in kidney fibrosis
Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 629
TGF-β signaling in vascular biology and dysfunction
Goumans, M.-J., Liu, Z., & ten Dijke, P. (2009) · Cell Research · doi:10.1038/cr.2008.326 · Cited by 601
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
Self-citationEndothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Ranchoux, B., Antigny, F., Rucker-Martin, C., Hautefort, A., Péchoux, C., Bogaard, H. J., Dorfmüller, P., Remy, S., Lecerf, F., Planté, S., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.008750 · Cited by 576
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Stone, J. H., Chan, J. K. C., Deshpande, V., Okazaki, K., Umehara, H., & Zen, Y. (2013) · International Journal of Rheumatology · doi:10.1155/2013/532612 · Cited by 558
The role of the ZEB family of transcription factors in development and disease
Vandewalle, C., Van Roy, F., & Berx, G. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8465-8 · Cited by 486
Nephrogenic Fibrosing Dermopathy
Cowper, S. E., Su, L. D., Bhawan, J., Robin, H. S., & LeBoit, P. E. (2001) · The American Journal of Dermatopathology · doi:10.1097/00000372-200110000-00001 · Cited by 475
Zeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
Fibroblasts and myofibroblasts: Their source, function and role in disease
McAnulty, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.11.005 · Cited by 456
Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Kawabe, T., Shimokata, K., & Hasegawa, Y. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0031oc · Cited by 451
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Barnes, J. L., & Gorin, Y. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 432
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., Ifedigbo, E., Xu, X., Oury, T. D., Kaminski, N., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061536 · Cited by 397
TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling
Cooley, B. C., Nevado, J., Mellad, J., Yang, D., St. Hilaire, C., Negro, A., Fang, F., Chen, G., San, H., Walts, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006927 · Cited by 392
Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D. W., Adiarto, S., Iwasa, N., Yagi, K., Miyagawa, K., Rikitake, Y., Suzuki, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.938217 · Cited by 385
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Corbı́, A., Attisano, L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104536200 · Cited by 380
Hinz, B. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0017-1 · Cited by 373 · cited 1×
“Furthermore, owing to their intrinsic contractile properties and their ability to establish rigid macromolecular stress fiber-like microfilament bundles in vivo, myofibroblasts induce changes in the biomechanical properties of the affected tissues causing a progressive increase in tissue stiffness, a newly recognized…”
BackgroundSlug is a direct Notch target required for initiation of cardiac cushion cellularization
Niessen, K., Fu, Y., Chang, L., Hoodless, P. A., McFadden, D., & Karsan, A. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710067 · Cited by 363
Kanasaki, K., Shi, S., Kanasaki, M., He, J., Nagai, T., Nakamura, Y., Ishigaki, Y., Kitada, M., Srivastava, S. P., & Koya, D. (2014) · Diabetes · doi:10.2337/db13-1029 · Cited by 359
Diseases caused by silica: mechanisms of injury and disease development
Ding, M., Chen, F., Shi, X., Yucesoy, B., Mossman, B., & Vallyathan, V. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00170-9 · Cited by 350
Good, R. B., Gilbane, A. J., Trinder, S. L., Denton, C. P., Coghlan, G., Abraham, D. J., & Holmes, A. M. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.03.019 · Cited by 349
Arciniegas, E., Frid, M. G., Douglas, I. S., & Stenmark, K. R. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00378.2006 · Cited by 341
Getting to the Heart of the Matter: New Insights Into Cardiac Fibrosis
Leask, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.305381 · Cited by 340
Amara, N., Goven, D., Prost, F., Muloway, R., Crestani, B., & Boczkowski, J. (2010) · Thorax · doi:10.1136/thx.2009.113456 · Cited by 337
Regulation of endothelial cell plasticity by TGF-β
van Meeteren, L. A., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1222-6 · Cited by 333
Transforming growth factor β—at the centre of systemic sclerosis
Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 332
Basic pathogenetic mechanisms in silicosis: current understanding
Rimal, B., Greenberg, A. K., & Rom, W. N. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000152998.11335.24 · Cited by 326
Inflammation-Induced Endothelial-to-Mesenchymal Transition
Rieder, F., Kessler, S. P., West, G. A., Bhilocha, S., de la Motte, C., Sadler, T. M., Gopalan, B., Stylianou, E., & Fiocchi, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.042 · Cited by 322
Medici, D., Potenta, S., & Kalluri, R. (2011) · Biochemical Journal · doi:10.1042/bj20101500 · Cited by 316
Li, J., Qu, X., & Bertram, J. F. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090096 · Cited by 316
Fibrosis—a lethal component of systemic sclerosis
Ho, Y. Y., Lagares, D., Tager, A. M., & Kapoor, M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.53 · Cited by 306
Chen, P.-Y., Qin, L., Barnes, C., Charisse, K., Yi, T., Zhang, X., Ali, R., Medina, P. P., Yu, J., Slack, F. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.021 · Cited by 304
Aisagbonhi, O., Rai, M., Ryzhov, S., Atria, N., Feoktistov, I., & Hatzopoulos, A. K. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006510 · Cited by 302
Diverse origins of the myofibroblast—implications for kidney fibrosis
Falke, L. L., Gholizadeh, S., Goldschmeding, R., Kok, R. J., & Nguyen, T. Q. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.246 · Cited by 299
Noseda, M., McLean, G., Niessen, K., Chang, L., Pollet, I., Montpetit, R., Shahidi, R., Dorovini-Zis, K., Li, L., Beckstead, B., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124300.76171.c9 · Cited by 294
Kumarswamy, R., Volkmann, I., Jazbutyte, V., Dangwal, S., Park, D.-H., & Thum, T. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234286 · Cited by 293
Radiation-induced and chemotherapy-induced pulmonary injury
Abid, S. H., Malhotra, V., & Perry, M. C. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200107000-00006 · Cited by 274
NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
Jiang, F., Liu, G.-S., Dusting, G. J., & Chan, E. C. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.012 · Cited by 270
Kumar, S., Kim, C. W., Simmons, R. D., & Jo, H. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303425 · Cited by 269
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Karsdal, M. A., Manon-Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N.-U. B., Bay-Jensen, A.-C., Bager, C. L., Krag, A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 263
Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature
Mendoza, F. A., Artlett, C. M., Sandorfi, N., Latinis, K., Piera-Velazquez, S., & Jimenez, S. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.08.002 · Cited by 262
Self-citationMicroRNAs and the regulation of fibrosis
Jiang, X., Tsitsiou, E., Herrick, S. E., & Lindsay, M. A. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07632.x · Cited by 258
Syn, W., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C. D., Yang, L., Wang, J., Witek, R. P., Fearing, C. M., Pereira, T. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.051 · Cited by 258
MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018174 · Cited by 244
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1
Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01256.x · Cited by 243
Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences
Richter, K., Konzack, A., Pihlajaniemi, T., Heljasvaara, R., & Kietzmann, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.015 · Cited by 238
Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
Kliment, C. R., & Oury, T. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.036 · Cited by 234
Diseases caused by asbestos: mechanisms of injury and disease development
Manning, C. B., Vallyathan, V., & Mossman, B. T. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00172-2 · Cited by 228
Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies
Rosenbloom, J., Castro, S. V., & Jimenez, S. A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00007 · Cited by 226
Self-citationWei, J., Fang, F., Lam, A. P., Sargent, J. L., Hamburg, E., Hinchcliff, M. E., Gottardi, C. J., Atit, R., Whitfield, M. L., & Varga, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34424 · Cited by 226
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
Fibrocytes in health and disease
Herzog, E. L., & Bucala, R. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.03.004 · Cited by 222
Role of NADPH Oxidases in Liver Fibrosis
Paik, Y.-H., Kim, J., Aoyama, T., De Minicis, S., Bataller, R., & Brenner, D. A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 219
Chagas Disease Cardiomyopathy: Immunopathology and Genetics
Cunha-Neto, E., & Chevillard, C. (2014) · Mediators of Inflammation · doi:10.1155/2014/683230 · Cited by 210
Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis
Ding, N.-H., Li, J., & Sun, L.-Q. (2013) · Current Drug Targets · doi:10.2174/13894501113149990198 · Cited by 206
Hedgehog-Gli Pathway Activation during Kidney Fibrosis
Fabian, S. L., Penchev, R. R., St-Jacques, B., Rao, A. N., Sipilä, P., West, K. A., McMahon, A. P., & Humphreys, B. D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.039 · Cited by 205
β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis
Beyer, C., Schramm, A., Akhmetshina, A., Dees, C., Kireva, T., Gelse, K., Sonnylal, S., de Crombrugghe, B., Taketo, M. M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200568 · Cited by 203
Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., & Mehrad, B. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309132 · Cited by 199
Sonic Hedgehog Signaling Mediates Epithelial–Mesenchymal Communication and Promotes Renal Fibrosis
Ding, H., Zhou, D., Hao, S., Zhou, L., He, W., Nie, J., Hou, F. F., & Liu, Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060614 · Cited by 198
A Role for Partial Endothelial–Mesenchymal Transitions in Angiogenesis?
Welch-Reardon, K. M., Wu, N., & Hughes, C. C. W. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303220 · Cited by 197
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
Hypoxia‐induced increase in the production of extracellular matrix proteins in systemic sclerosis
Distler, J. H. W., Jüngel, A., Pileckyte, M., Zwerina, J., Michel, B. A., Gay, R. E., Kowal‐Bielecka, O., Matucci‐Cerinic, M., Schett, G., Marti, H. H., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23074 · Cited by 193
Notch and disease: A growing field
Louvi, A., & Artavanis-Tsakonas, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.005 · Cited by 192
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394307-1.00003-5 · Cited by 190
Matrix Elasticity, Cytoskeletal Tension, and TGF-β: The Insoluble and Soluble Meet
Wells, R. G., & Discher, D. E. (2008) · Science Signaling · doi:10.1126/stke.110pe13 · Cited by 183
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy: A Narrative Review
Gökmen, M. R., Cosyns, J.-P., Arlt, V. M., Stiborová, M., Phillips, D. H., Schmeiser, H. H., Simmonds, M. S. J., Cook, H. T., Vanherweghem, J.-L., Nortier, J. L., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-6-201303190-00006 · Cited by 182
Jimenez, S. A., Hitraya, E., & Varga, J. (1996) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70294-5 · Cited by 181
Self-citationChoi, S.-H., Hong, Z.-Y., Nam, J.-K., Lee, H.-J., Jang, J., Yoo, R. J., Lee, Y. J., Lee, C. Y., Kim, K. H., Park, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3193 · Cited by 178
The role of endothelial-mesenchymal transition in development and pathological process
Lin, F., Wang, N., & Zhang, T. (2012) · IUBMB Life · doi:10.1002/iub.1059 · Cited by 177
Sonic Hedgehog Signaling in the Lung. From Development to Disease
Kugler, M. C., Joyner, A. L., Loomis, C. A., & Munger, J. S. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0132tr · Cited by 177
Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis
Postlethwaite, A. E., Shigemitsu, H., & Kanangat, S. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000139310.77347.9c · Cited by 174
Noncoding RNAs and myocardial fibrosis
Thum, T. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.125 · Cited by 173
Ghosh, A. K., Nagpal, V., Covington, J. W., Michaels, M. A., & Vaughan, D. E. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.024 · Cited by 170
Strategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jimenez, S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 170
Self-citationXu, X., Tan, X., Tampe, B., Sanchez, E., Zeisberg, M., & Zeisberg, E. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636944 · Cited by 168
Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
He, J., Xu, Y., Koya, D., & Kanasaki, K. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0781-0 · Cited by 167
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
Shi, S., Srivastava, S. P., Kanasaki, M., He, J., Kitada, M., Nagai, T., Nitta, K., Takagi, S., Kanasaki, K., & Koya, D. (2015) · Kidney International · doi:10.1038/ki.2015.103 · Cited by 166
New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
Abraham, D. J., Eckes, B., Rajkumar, V., & Krieg, T. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0008-z · Cited by 166
Galdo, F. D., Sotgia, F., de Almeida, C. J., Jasmin, J., Musick, M., Lisanti, M. P., & Jiménez, S. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23791 · Cited by 165
Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodriguez, C. M., Pinedo, F., Huber, H., Eferl, R., Mikulits, W., & Fabregat, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045285 · Cited by 165
Chang, A. C. Y., Fu, Y., Garside, V. C., Niessen, K., Chang, L., Fuller, M., Setiadi, A., Smrz, J., Kyle, A., Minchinton, A., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.022 · Cited by 164
MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis
Bowen, T., Jenkins, R. H., & Fraser, D. J. (2013) · The Journal of Pathology · doi:10.1002/path.4119 · Cited by 163
Lam, A. P., Flozak, A. S., Russell, S., Wei, J., Jain, M., Mutlu, G. M., Budinger, G. R. S., Feghali‐Bostwick, C. A., Varga, J., & Gottardi, C. J. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0113oc · Cited by 163
Role of Sonic Hedgehog in idiopathic pulmonary fibrosis
Bolaños, A. L., Milla, C. M., Lira, J. C., Ramírez, R., Checa, M., Barrera, L., García-Alvarez, J., Carbajal, V., Becerril, C., Gaxiola, M., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2012 · Cited by 160
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 160
Goumans, M.-J., van Zonneveld, A. J., & ten Dijke, P. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.01.001 · Cited by 159
Kirk, T. Z., Mark, M. E., Chua, C. C., Chua, B. H., & Mayes, M. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3423 · Cited by 158
Xavier, S., Vasko, R., Matsumoto, K., Zullo, J. A., Chen, R., Maizel, J., Chander, P. N., & Goligorsky, M. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101137 · Cited by 158
Li, L., Chen, L., Zang, J., Tang, X., Liu, Y., Zhang, J., Bai, L., Yin, Q., Lu, Y., Cheng, J., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.014 · Cited by 157
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo
Tourkina, E., Richard, M., Göőz, P., Bonner, M., Pannu, J., Harley, R. A., Bernatchez, P. N., Sessa, W. C., Silver, R. M., & Hoffman, S. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2007 · Cited by 157
miRNAs regulate expression and function of extracellular matrix molecules
Rutnam, Z. J., Wight, T. N., & Yang, B. B. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.003 · Cited by 148
Xu, X., Tan, X., Tampe, B., Nyamsuren, G., Liu, X., Maier, L. S., Sossalla, S. T., Kalluri, R., Zeisberg, M., Hasenfuss, G. P., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv015 · Cited by 145
Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
Beyer, C., Schett, G. A., Gay, S., Distler, O., & Distler, J. H. W. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2598 · Cited by 145
Jiménez, S. A. (2013) · ISRN Rheumatology · doi:10.1155/2013/835948 · Cited by 140
Roles of TGF-βSignals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
Yoshimatsu, Y., & Watabe, T. (2011) · International Journal of Inflammation · doi:10.4061/2011/724080 · Cited by 139
Idiopathic pulmonary fibrosis: An update
Spagnolo, P., Sverzellati, N., Rossi, G., Cavazza, A., Τzouvelekis, Α., Crestani, B., & Vancheri, C. (2015) · Annals of Medicine · doi:10.3109/07853890.2014.982165 · Cited by 134
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
Srivastava, S. P., Koya, D., & Kanasaki, K. (2013) · BioMed Research International · doi:10.1155/2013/125469 · Cited by 133
Galdo, F. D., Lisanti, M. P., & Jiménez, S. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283103d27 · Cited by 132
Wang, Y., Stricker, H. M., 苟德明, & Liu, L. (2006) · Frontiers in bioscience · doi:10.2741/2234 · Cited by 130
Matrix Biology of Idiopathic Pulmonary Fibrosis
Thannickal, V. J., Henke, C. A., Horowitz, J. C., Noble, P. W., Roman, J., Sime, P. J., Zhou, Y., Wells, R. G., White, E. S., & Tschumperlin, D. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.003 · Cited by 128
Piera-Velázquez, S., & Jiménez, S. A. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s7 · Cited by 122
Mendoza, F. A., Piera‐Velazquez, S., Farber, J. L., Feghali‐Bostwick, C., & Jiménez, S. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39421 · Cited by 121
Self-citationMolecular markers of cardiac endocardial cushion development
Gitler, A. D., Lu, M. M., Jiang, Y. Q., Epstein, J. A., & Gruber, P. J. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10418 · Cited by 121
Role of caveolin-1 in fibrotic diseases
Gvaramia, D., Blaauboer, M. E., Hanemaaijer, R., & Everts, V. E. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.03.005 · Cited by 120
Cipriani, P., Benedetto, P. D., Ruscitti, P., Capece, D., Zazzeroni, F., Liakouli, V., Pantano, I., Berardicurti, O., Carubbi, F., Pecetti, G., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150088 · Cited by 120
Cheng, S., Shao, J.-S., Behrmann, A., Krchma, K., & Towler, D. A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.300647 · Cited by 118
The potential of microRNAs in liver fibrosis
He, Y., Huang, C. Z., Zhang, S., Sun, X., Long, X., & Li, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.023 · Cited by 116
Jiménez, S. A., & Piera-Velázquez, S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.012 · Cited by 115
Fu, Y., Chang, A. C. Y., Chang, L., Niessen, K. S., Eapen, S., Setiadi, A., & Karsan, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011833 · Cited by 114
The myofibroblast: a key cell for wound healing and fibrocontractive diseases.
Gabbiani, G. (1981) · PubMed · Cited by 113
Wermuth, P. J., Li, Z., Mendoza, F. A., & Jiménez, S. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161988 · Cited by 110
Self-citationEndothelial-Mesenchymal Transition Occurs during Embryonic Pulmonary Artery Development
Arciniegas, E., Neves, C. Y., Carrillo, L. M., Zambrano, E. A., & Ramírez, R. (2005) · Endothelium · doi:10.1080/10623320500227283 · Cited by 107
Hu, B., & Phan, S. H. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835b1352 · Cited by 107
Chrobak, I., Lenna, S., Stawski, L., & Trojanowska, M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24337 · Cited by 102
Charytan, D. M., Padera, R. F., Helfand, A. M., Zeisberg, M., Xu, X., Liu, X., Himmelfarb, J., Cinelli, A., Kalluri, R., & Zeisberg, E. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.062 · Cited by 101
The role of microRNAs in skin fibrosis
Babalola, O., Mamalis, A., Lev‐Tov, H. A., & Jagdeo, J. R. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1410-1 · Cited by 101
Review: Endothelial‐myofibroblast transition, a new player in diabetic renal fibrosis
Li, J., & Bertram, J. F. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01319.x · Cited by 101
Li, Z., & Jiménez, S. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30317 · Cited by 99
Transforming growth factor-beta in systemic sclerosis scleroderma
Varga, J., & Whitfield, M. L. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s22 · Cited by 97
Jasmin, J.-F., Mercier, I., Dupuis, J., Tanowitz, H. B., & Lisanti, M. P. (2006) · Circulation · doi:10.1161/circulationaha.106.634709 · Cited by 97
Kitao, A., Sato, Y., Sawada‐Kitamura, S., Harada, K., Sasaki, M., Morikawa, H., Shiomi, S., Honda, M., Matsui, O., & Nakanuma, Y. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081061 · Cited by 92
Pathophysiological Consequences of HIF Activation: HIF as a Modulator of Fibrosis
Haase, V. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05030.x · Cited by 92
Guo, Y., Li, P., Bledsoe, G., Yang, Z., Chao, L., & Chao, J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.06.021 · Cited by 91
Zhang, J., Zhang, Z., Zhang, D. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083294 · Cited by 88
Nagai, T., Kanasaki, M., Srivastava, S. P., Nakamura, Y., Ishigaki, Y., Kitada, M., Shi, S., Kanasaki, K., & Koya, D. (2014) · BioMed Research International · doi:10.1155/2014/696475 · Cited by 88
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
Zhou, X., Chen, X., Cai, J., Chen, L. Z., Gong, Y. S., Wang, L. X., Gao, Z., Zhang, H. Q., Huang, W. J., & Zhou, H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s85399 · Cited by 87
MicroRNA regulatory networks in idiopathic pulmonary fibrosis
Pandit, K. V., & Milošević, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0101 · Cited by 87
In Brief: Endothelial‐to‐mesenchymal transition
Sánchez‐Duffhues, G., Orlova, V. V., & ten Dijke, P. (2015) · The Journal of Pathology · doi:10.1002/path.4653 · Cited by 75
Systemic sclerosis: from pathogenesis to targeted therapy.
Denton, C. P. (2015) · PubMed · Cited by 73
Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis
Crestani, B., Besnard, V., & Boczkowski, J. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.04.003 · Cited by 72
Canonical Wnt signaling in systemic sclerosis
Bergmann, C., & Distler, J. H. W. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.154 · Cited by 69
Spadoni, T., Svegliati, S., Amico, D., Albani, L., Moroncini, G., Avvedimento, E. V., & Gabrielli, A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39084 · Cited by 66
Li, Z., Wermuth, P. J., Benn, B. S., Lisanti, M. P., & Jiménez, S. A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.022 · Cited by 61
Zhu, H., Luo, H., & Zuo, X. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.71 · Cited by 56
Katsura, A., Suzuki, H. I., Ueno, T., Mihira, H., Yamazaki, T., Yasuda, T., Watabe, T., Mano, H., Yamada, Y., & Miyazono, K. (2015) · Genes to Cells · doi:10.1111/gtc.12323 · Cited by 56
Piera-Velázquez, S., Makul, A., & Jiménez, S. A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39242 · Cited by 53
Mintet, E., Rannou, E., Buard, V., West, G. A., Guipaud, O., Tarlet, G., Sabourin, J., Benderitter, M., Fiocchi, C., Milliat, F., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.028 · Cited by 53
Bourji, K. I., Meyer, A., Chatelus, E., Pincemail, J., Pigatto, E., Defraigne, J.-O., Singh, F., Charlier, C., Gény, B., Gottenberg, J., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.002 · Cited by 52
Siani, A., & Tirelli, N. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5724 · Cited by 49
Castelino, F. V., & Varga, J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000110 · Cited by 46
Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges
White, J. M., Creamer, D., du Vivier, A. W. P., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07827.x · Cited by 46
Sadler, T. M., Scarpa, M., Rieder, F., West, G. A., & Stylianou, E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f37a · Cited by 44
Distler, A., Lang, V. R., Vecchio, T. D., Huang, J., Zhang, Y., Beyer, C., Lin, N., Palumbo‐Zerr, K., Distler, O., Schett, G. A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204221 · Cited by 38
Jiménez, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.6222 · Cited by 34
Role of endothelin-1 in the skin fibrosis of systemic sclerosis
Jing, J., Dou, T., Yang, J. Q., Chen, X. B., Cao, H.-L., Min, M., Cai, S., Zheng, M., & Man, X. (2015) · European Cytokine Network · doi:10.1684/ecn.2015.0360 · Cited by 33
Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.116.022627 · Cited by 30
Contemporary Assessment of Hepatic Fibrosis
Bonder, A., Tapper, E. B., & Afdhal, N. H. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.09.007 · Cited by 29
Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis
Jiménez, S. A., Castro, S. V., & Piera-Velázquez, S. (2010) · Current Rheumatology Reviews · doi:10.2174/157339710793205611 · Cited by 29
Cited by
Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
Piera-Velazquez, S., & Jimenez, S. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00021.2018 · Cited by 662
Self-citationEndothelial to Mesenchymal Transition in Cardiovascular Disease
Kovacic, J. C., Dimmeler, S., Harvey, R. P., Finkel, T., Aikawa, E., Krenning, G., & Baker, A. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.089 · Cited by 631
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538
Bai, Y., Zhang, Y., Han, B., Yang, L., Chen, X., Huang, R., Wu, F., Chao, J., Liu, P., Hu, G., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1348-17.2017 · Cited by 379
Pathophysiology of systemic sclerosis: current understanding and new insights
Cutolo, M., Soldano, S., & Smith, V. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1614915 · Cited by 369
Metadata
- Authors
- Piera-Velazquez, S., Mendoza, F., & Jimenez, S.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2016-04-11
- Volume
- 5
- Issue
- 4
- Pages
- 45
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2332128473
- Cited by
- 273
- References
- 180
- FWCI
- 28.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.